Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. It blocks viral entry into host cells while preserving normal immunologic function. The Company is also investigating an intramuscular method of administration of Trogarzo. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy.

TSX:TH - Post by User

Theratechnologies Inc > Volume

<< Previous

Bullboard Posts

Next >>

Comment by Biobobon Aug 04, 2022 1:35pm

96 Views

Post# 34871596

RE:RE:RE:RE:Volume

At some point big shareholders like Soleus will stick it to Paul and the board and do something about the total and absolute lack of any value whatsoever of shareholder value for all the money they spend and borrow and dilute for while perfect scams like CYDY and many inflated stories.. just stories get the valuations we are aiming for with a POC on a cancer platform... like sh t enouigh is enough..

<< Previous

Bullboard Posts

Next >>

Nextech CEO provides company update on Amazon deal and more